| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 99614-70-7 | carbazol-4-one hydrochloride | C16H20N2O.HCl;C16H21ClN2O |
| 99614-77-4 | 3'-Azido-3'-Deoxyarabinothymidine | C10H13N5O5 |
| 99615-01-7 | 5,8,4'-Trihydroxy-6,7,3'-trimethoxyflavone | C18H16O8 |
| 99615-36-8 | 2-(3,4-Dimethoxyphenyl)-N-(2-pyridinylmethyl)ethanamine | C16H20N2O2 |
| 99615-55-1 | 6-(Chloroacetyl)-2(3H)-benzothiazolone | C9H6ClNO2S |
| 99615-68-6 | 2,3-Dihydro-2-oxo-6-benzothiazolecarboxylic acid | C8H5NO3S |
| 99615-99-3 | Clarkeanidine | C19H21NO4 |
| 99616-00-9 | 5,6-Epoxy-1-Hydroxy-6-Isopropyl-3,11-Dimethyl-3-Azatricyclo[6.2.1.04(5,11)]Undecan-2-One | C16H23NO4 |
| 99616-15-6 | 4-Azidoclonidine | C9H8Cl2N6 |
| 99616-64-5 | Metronidazole | C6H9N3O3 |
| 99617-34-2 | 4-Amino-N-(1-azabicyclo[2.2.2]oct-3-yl)-5-chloro-2-methoxybenzamide | C15H20ClN3O2 |
| 99623-07-1 | N-Hydroxyheptanimidamide | C7H16N2O |
| 99623-08-2 | N'-Hydroxycyclobutanecarboximidamide | C5H10N2O |
| 99623-12-8 | N'-Hydroxycyclopentanecarboximidamide | C6H12N2O |
| 99624-08-5 | 7-Hydroxytrichodermol | C15H22O4 |
| 99624-27-8 | Kazinol B | C25H28O4 |
| 99624-28-9 | (-)-Kazinol A | C25H30O4 |
| 99624-39-2 | [1R-[1alpha(E),4abeta,5beta,6alpha,8aalpha]]-5-[Decahydro-6-hydroxy-5-(hydroxymethyl)-5,8a-dimethyl-2-methylene-1-naphthalenyl]-3-methyl-2-pentenoic acid | C20H32O4 |
| 99624-52-9 | L-Valylglycyl-N-[(1S)-1,3-dicarboxylatopropyl]-L-alpha-asparagine | C16H24N4O9 |
| 99624-67-6 | Paeonimetabolin I | C10H14O4 |
| 99624-68-7 | omega-1-Hydroxy Fentanyl | C22H28N2O2 |
| 99624-92-7 | Uncinatone | C20H22O4 |
| 99626-88-7 | Toluene-4-Isocyanate-2-Amine | C8H8N2O |
| 99627-05-1 | 3,4,5-Trifluorophenol | C6H3F3O |
| 99627-63-1 | Pentamethyl 1,1,3,3,5-cyclohexanepentacarboxylate | C16H22O10 |
| 99629-34-2 | (2Z)-2-Cyano-N-(Ethylcarbamoyl)-2-Methoxyimino-Acetamide: N-(2,6-Dimet Hylphenyl)-2-Methoxy-N-(2-Oxooxazolidin-3-Yl)Acetamide: Manganese(+2) Cation: [2-(Sulfidocarbothioylamino)Ethylamino]Methanedithioate: Zinc( +2) Cation | C29H40MnN10O7S8Zn |
| 99629-62-6 | N-(4-(((2-((4-Ethoxyphenyl)Imino)-4-Oxo-3-Thiazolidinyl)Amino)Carbonyl)Phenyl)-3,4,5-Trimethoxy-Benzamide | C28H28N4O7S |
| 99631-79-5 | N-2-Naphthalenyl-L-leucine | C16H19NO2 |
| 99632-94-7 | 5,6-Dihydro-5-Methyl-6-Oxo-4H-Imidazo[1,5-A]Thieno[2,3-F][1,4]Diazepine-3-Carboxylic Acid 1,1-Dimethylethyl Ester | C15H17N3O3S |
| 99633-05-3 | Neoline 14-benzoate | C31H43NO7 |
| 99633-82-6 | (2S)-2-Amino-4-[[2-Hydroxy-2-(4-Hydroxyphenyl)Ethyl]Carbamoyl]Butanoic Acid | C13H18N2O5 |
| 99634-12-5 | 5-(Hydroxymethyl)-3-[5-(Hydroxymethyl)-3,5-Dimethyl-2-Oxomorpholin-3-Yl]-3,5-Dimethylmorpholin-2-One | C14H24N2O6 |
| 99634-56-7 | N-[4-(4-Aminobenzyl)phenyl]benzamide | C20H18N2O |
| 99635-24-2 | (1R-(1alpha(Z),2beta(1E,3S*),5alpha))-5-Bromo-2'-Deoxycytidylyl-(5'-3')-2'-DeoxyGuanosine | C19H24BrN8O10P |
| 99636-32-5 | (S)-2-Amino-1-methoxypropane | C4H11NO |
| 99636-38-1 | (R)-1-Methoxy-2-propanamine | C4H11NO |
| 99643-42-2 | 2,2-Spirobi(naphtho(1,8-de)-1,3-dithiin | |
| 99643-43-3 | Spiro[2H-benzimidazole-2,2'(3'H)-[1H]perimidine],1,3-dihydro-1,1',3,3'-tetramethyl- | |
| 99644-93-6 | 1-(1,4-Dimethyl-1H-pyrazol-3-yl)ethanone | C7H10N2O |
| 99646-11-4 | 2-(2-Hydroxy-2-propanyl)-2-methylcyclohexanone | C10H18O2 |
| 99646-28-3 | (S)-(-)-2,2'-Bis(di-p-tolylphosphino)-1,1'-binaphthyl | C48H40P2 |
| 99647-70-8 | 3-[(3E)-3-Penten-2-yl]-1,2-benzenediamine | C11H16N2 |
| 99655-68-2 | 3-Bromo-(1-phenylsulfonyl)indole | C14H10BrNO2S |
| 99658-03-4 | alpha-Helical corticotropin releasing factor fragment | C166H273N45O54S2 |
| 99658-04-5 | lucagon-related peptide I (ox) | |
| 99658-59-0 | 8-Methyl-8-azabicyclo[3.2.1]octane-2-carbaldehyde | C9H15NO |
| 99658-60-3 | 8-Methyl-8-azabicyclo[3.2.1]octane-2-carbaldehyde | C9H15NO |
| 99658-61-4 | 8-Methyl-8-azabicyclo[3.2.1]octane-3-carbaldehyde | C9H15NO |
| 99660-13-6 | Phe-cyclo(cys-tyr-trp-lys-val-cys)thr-NH2 | C50H67N11O10S2 |
| 99660-94-3 | 1,2,3-Trieicosapentaenoyl Glycerol | C63H92O6 |